2m 2m 2m 2m 2m 2m 2m
JAGUAR HEALTH (JAGX)
NASDAQ
$2.96-$0.27 (-8.23%)
Price as of Jun 03, 2026 7:11 PM EDT- $2.3MMarket Cap
- -97.57%1-Year Change
- BiotechnologyIndustry
JAGUAR HEALTH (JAGX)
$2.96-$0.27 (-8.23%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 11.3M -1.91% | 11.6M -40.78% | 19.5M +63.28% | 12.0M +37.90% | |
Cost of Revenue | 3.8M +93.04% | 2.0M -4.03% | 2.0M +0.89% | 2.0M -13.46% | |
Gross Profit | 7.6M -21.24% | 9.6M -45.07% | 17.5M +75.96% | 9.9M +56.81% | |
Sales and Marketing Expense | 9.2M +20.06% | 7.7M +19.07% | 6.5M -26.90% | 8.8M -0.64% | |
Research and Development Expense | -25.0M +50.92% | -16.5M -11.05% | -18.6M +5.38% | -17.6M +17.03% | |
Depreciation and Amortization Expense | 1.9M +0.68% | 1.9M -5.61% | 2.0M +1.62% | 2.0M +15.24% | |
Total Operating Expenses | 57.4M +35.04% | 42.5M -3.48% | 44.1M -5.00% | 46.4M +2.95% | |
Operating Profit | -45.9M +116,863.06% | -39,250 -99.89% | -34.3M -0.36% | -34.4M -15.46% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -67,000 -71.00% | -231,000 -96.38% | -6.4M -49.84% | -12.7M +51.09% | |
Interest Income and Expense and Net | -67,000 -71.00% | -231,000 -96.38% | -6.4M -49.84% | -12.7M +51.09% | |
Total Nonoperating Income and Expense | 43,000 -15.69% | 51,000 -74.50% | 200,000 -78.95% | 950,000 +224.18% | |
Income before Taxes | -54.0M +137,471.97% | -39,250 -99.91% | -41.9M -13.42% | -48.4M -7.99% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Net Income | -54.0M +137,471.97% | -39,250 -99.91% | -41.9M -13.42% | -48.4M -7.99% | |
Net Income from Continuing Operations Applicable to Common | -53.6M +136,396.82% | -39,250 -99.90% | -41.3M -12.97% | -47.5M -9.77% | |
Basic EPS and Net Income | -22.97 -82.42% | -130.69 +7,201.12% | -1.79 -95.05% | -36.18 +2,966.10% | |
Diluted EPS and Net Income | -22.97 -82.42% | -130.69 +7,201.12% | -1.79 -95.05% | -36.18 +2,966.10% | |
Basic Weighted Average Shares | 2.3M +691.90% | 294,534 -98.72% | 23.1M +1,658.91% | 1.3M -97.07% | |
Diluted Weighted Average Shares | 2.3M +691.90% | 294,534 -98.72% | 23.1M +1,658.91% | 1.3M -97.07% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 968,000 -87.90% | 8.0M +23.70% | 6.5M +18.28% | 5.5M -67.93% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 968,000 -87.90% | 8.0M +23.70% | 6.5M +18.28% | 5.5M -67.93% | |
Total Current Assets | 20.3M -36.81% | 32.2M +15.15% | 28.0M +25.28% | 22.3M -21.50% | |
Accumulated Depreciation | 558,000 +8.77% | 513,000 +10.32% | 465,000 +15.10% | 404,000 +35.57% | |
Property and Plant and Equipment and Net | 463,000 -0.22% | 464,000 -6.45% | 496,000 -10.95% | 557,000 -14.31% | |
Total Long-Term Assets | 494,000 -63.35% | 1.3M +33.20% | 1.0M +1.71% | 995,000 +123.09% | |
Total Assets | 38.3M -28.27% | 53.4M +5.24% | 50.8M +6.98% | 47.5M -10.91% | |
Income Taxes Payable | 12,000 -7.69% | 13,000 -89.34% | 122,000 +1,255.56% | 9,000 -96.84% | |
Total Short-Term Debt | 27.4M +127.94% | 12.0M +147.34% | 4.9M -69.36% | 15.9M +398.84% | |
Total Current Liabilities | 40.7M +106.32% | 19.7M +40.87% | 14.0M -53.90% | 30.3M +96.10% | |
Total Long-Term Debt | 15.1M -35.83% | 23.5M -24.17% | 31.0M +74.67% | 17.7M -29.09% | |
Total Long-Term Liabilities | 16.4M -33.89% | 24.7M -22.39% | 31.9M +72.60% | 18.5M -28.80% | |
Total Liabilities | 57.0M +28.27% | 44.4M -3.10% | 45.9M -6.03% | 48.8M +17.86% | |
Retained Earnings | -399.9M +15.42% | -346.5M +12.40% | -308.2M +15.47% | -266.9M +21.62% | |
Total Stockholders Equity | -18.7M -387.77% | 6.5M +32.61% | 4.9M +461.14% | -1.4M -111.44% | |
Total Shares Outstanding | 7.0M +1,220.21% | 528,440 -99.28% | 73.1M +1,599.87% | 4.3M -91.47% | |
Cash Flow | |||||
Cash from Operating Activities | -23.7M -19.39% | -29.4M -11.61% | -33.2M +0.42% | -33.1M -5.34% | |
Capital Expenditures | 16,000 0.00% | 16,000 -79.22% | 77,000 0.00% | 77,000 +1,183.33% | |
Cash from Investing Activities | -41,000 -82.25% | -231,000 -86.21% | -1.7M 0.00% | -1.7M +27,816.67% | |
Dividends Paid | N/A N/A | 1.2M 0.00% | 1.2M N/A | N/A N/A | |
Cash from Financing Activities | 23.7M -24.14% | 31.2M -8.84% | 34.2M +47.65% | 23.2M -47.24% | |
Financials Ratio | |||||
Gross Margin | 66.72% -19.70% | 83.09% -7.23% | 89.57% +7.76% | 83.11% +13.71% | |
Operating Margin | -404.87% +119,154.26% | -0.34% -99.81% | -175.65% -38.98% | -287.85% -38.69% | |
Return on Assets | -117.71% +156,217.66% | -0.08% -99.91% | -85.33% -11.21% | -96.10% -12.20% | |
Return on Equity | 885.63% +128,620.14% | -0.69% -99.97% | -2,366.62% +156.66% | -922.07% +154.67% | |
Revenue Growth | -1.91% -95.31% | -40.78% -164.45% | 63.28% +66.97% | 37.90% +597.48% | |
Current Ratio | 0.50 -69.38% | 1.63 -18.26% | 2.00 +171.74% | 0.74 -59.97% | |
Cash Ratio | 0.02 -94.14% | 0.41 -12.19% | 0.46 +156.52% | 0.18 -83.64% | |
Debt-to-Equity Ratio | -2.28 -141.58% | 5.47 -25.26% | 7.32 +129.53% | -24.80 -1,142.09% | |
Debt-to-Assets Ratio | 1.11 +66.78% | 0.67 -5.82% | 0.71 -0.32% | 0.71 +33.84% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow